Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Regulatory News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.75
Bid: 13.50
Ask: 14.00
Change: -0.25 (-1.79%)
Spread: 0.50 (3.704%)
Open: 14.00
High: 14.00
Low: 13.75
Prev. Close: 14.00
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Re US Venture -- Aberro

17 Nov 2005 07:02

Angle PLC17 November 2005 For Immediate Release 17 November 2005 ANGLE PLC US VENTURE, ABERRO: PRODUCT IN BETA TRIALS ANGLE is delighted to announce that it has officially launched Aberro, asoftware testing company (formerly known as ContraSoft). Aberro is 57 per cent.owned by ANGLE and is ANGLE's first US venture founded since ANGLE's flotationin 2004. Aberro has developed a beta release of its product, AberroTest, which is in useat several companies. The product solves a number of issues in the softwareindustry and is expected to be released commercially later this year. Aberro ispreviewing the technology at STARWEST, the world's largest software testingevent, which is being held this week in Anaheim, California. A recent IDC report projected that in 2006, companies will spend over $1 billionon tools to help improve their software testing capabilities. Aberro's AdaptiveAutomated Testing delivers easy and rapid test creation, with no programmingskills required, coupled with low-cost execution that automatically adapts tochanges in the target application. With Aberro's technology, tests areautomatically created in a matter of minutes. This allows testers to find andrepair defects sooner and more easily, while reducing development costs andimproving overall software quality. In developing Aberro, ANGLE has assembled an experienced management team headedby CEO Douglas Smith and Vice President of Marketing Steve Lafferty. Smithjoined the company from ANGLE, where he served as an Entrepreneur in Residence.He has over 20 years of management experience, including CEO and COO roles atthree start-up companies and senior management positions at Digital Equipment,Compaq and EMC. Lafferty previously served as Business Unit Director withManugistics and has held senior-level marketing roles at Cadre, Iona, SterlingSoftware and Green Hills Software. Additionally, Aberro's Co-Founder and CTO William Rogers, Ph.D., brings over 20years of research and development experience to the team. Rogers was theoriginator of Aberro's revolutionary software testing technique, AdaptiveAutomated Testing, which enables rigorous automated testing of software farearlier than any other solution on the market. Rob Kornblum, Managing Director of ANGLE Ventures (US) said: "We are delighted with our progress at Aberro in delivering product to betausers so rapidly. We already see a tremendous amount of interest in Aberro'sproducts from the software community." For more information: ANGLE plc 01483 295830 Andrew Newland, Group CEO Buchanan Communications 020 7466 5000 Richard Darby, Suzanne Brocks, James Strong Notes to Editors Founded in 1994, ANGLE is an international venture management and consultingcompany focusing on the commercialisation of technology and the development oftechnology-based industry. ANGLE creates, develops and advises technologybusinesses on its own behalf and for its clients. ANGLE is listed on AIM (AGL.L)and operates from offices in the UK, the US and the Middle East. Further information can be found on www.ANGLEplc.com For more information on Aberro, please visit www.aberrosoftware.com or contactSteve Lafferty at 240.715 3333 x208. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th Mar 20128:00 amRNSHolding(s) in the Company
28th Feb 201212:00 pmRNSDirector Share Transfer
28th Feb 20128:00 amRNSTotal Voting Rights
27th Feb 20127:00 amRNSParsortix Research Partnership
22nd Feb 20127:00 amRNSSecond Novocellus Patent
26th Jan 20127:00 amRNSInterim Results
26th Jan 20127:00 amRNSNovocellus Update
26th Jan 20127:00 amRNSFundraising
23rd Jan 20127:01 amRNSParsortix Update
19th Jan 20127:00 amRNSNotice of Interim Results and Webcast
16th Dec 20117:00 amRNSParsortix Update - Validation for Lung Cancer
7th Dec 20117:00 amRNSParsortix Update
21st Nov 20117:00 amRNSShare Options
16th Nov 20117:00 amRNSNovocellus Update
15th Nov 20117:00 amRNSIssue of equity and Total Voting Rights
11th Nov 20117:00 amRNSValidation for Prostate Cancer
10th Nov 20117:00 amRNSChange of Adviser
7th Nov 20113:53 pmRNSACOLYTE BIOMEDICA COURT JUDGEMENT
31st Oct 20117:00 amRNSWORLD TECHNOLOGY NETWORK AWARD
27th Oct 20119:26 amRNSDirector's share transfer
24th Oct 20117:00 amRNSPortfolio Company Announces Strengthening Sales
12th Oct 20117:00 amRNSIssue of equity and Total Voting Rights
6th Oct 20112:33 pmRNSResults of 2011 Annual General Meeting
6th Oct 20117:00 amRNS2011 AGM Statement
5th Oct 20117:00 amRNSParsortix Update and Issue of Equity
4th Oct 20117:00 amRNSWEB CAST - Parsortix Update
28th Sep 20117:00 amRNSParsortix Update
15th Sep 20113:20 pmRNSHolding(s) in Company
14th Sep 20119:16 amRNSAnnual Report and Accounts and Notice of AGM
13th Sep 20113:54 pmRNSHolding(s) in Company
12th Sep 20112:53 pmRNSHolding(s) in Company
8th Sep 20115:26 pmRNSHolding(s) in Company
31st Aug 20112:44 pmRNSShare Options
26th Aug 20114:26 pmRNSHolding in Company
17th Aug 20117:00 amRNSIssue of equity and Total Voting Rights
28th Jul 20117:00 amRNSPreliminary Results
25th Jul 20117:00 amRNSGeomerics Announces Agreement with Epic Games
15th Jul 20117:00 amRNSConditional Fundraising
28th Jun 20117:00 amRNSParsortix Update
18th May 20117:00 amRNSAcolyte Biomedica Update
5th May 20117:00 amRNSParsortix Update
28th Apr 20117:00 amRNSGeomerics Corporate Deal Further Progress
14th Apr 20117:00 amRNSGeomerics progress
2nd Mar 20114:54 pmRNSDirector/PDMR Shareholding
1st Mar 20117:00 amRNSGeomerics Real-Status deal
27th Jan 20117:00 amRNSInterim Results
25th Jan 20119:00 amRNSNotice of Interim Results
12th Jan 20117:00 amRNSGeometrics Corporate Deal Update
7th Jan 20117:00 amRNSNeuroTargets Patent Grant
6th Dec 201011:38 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.